SCHEMBL3847544

SCHEMBL3847544

Clc1cc(-c2cnn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2)cn2c(-c3ccccn3)cnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.37
KDR P35968 2/20 0.34
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA3 P34903 1/20 0.33
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 1/20 0.32
GRM5 P41594 1/20 0.32
MAPT P10636 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
NPY5R Q15761 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845293 0.83 KDR (0.42) METKDRKCNN4KCNA3
SCHEMBL3844953 0.81 MET (0.36) METNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3847545 0.81 MET (0.33) MET
SCHEMBL4713313 0.81 IRAK4 (0.41) GABRA1GABRG2GABRB3GABRA3
SCHEMBL3847277 0.78 SMN1; SMN2 (0.36) KDRGABRA1GABRG2GABRB3GABRA3
SCHEMBL3847999 0.76 KCNN4 (0.38) METNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL70574 0.68 L3MBTL1 (0.44) KDRNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL580662 0.67 NPC1 (0.39) KDRNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3851626 0.67 TGFBR1 (0.38) GABRA1GABRG2GABRB3GABRA3NPC1
SCHEMBL3826876 0.66 KCNN4 (0.33) NPC1RAB9ASMN1; SMN2KCNN4KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed